To access this element change to forms mode OFF
Grant Award View - GA201500
Advancing peptide-based drug design
GA ID:
GA201500
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$3,177,015.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Advancing peptide-based drug design
Purpose:
I will use molecules called peptides to make safer, more effective medicines. These next-generation drugs will have fewer side effects than existing drugs due to their highly specific interactions with their target sites in the body. In the past pharmaceutical companies have not been able to utilise peptides because of technical challenges associated with their synthesis and delivery. My work has led to solutions to these problems that will be exploited to develop new drugs for pain and cancer.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009564
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA